These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 35233795)

  • 1. Gut dysbiosis and long COVID-19: Feeling gutted.
    Giannos P; Prokopidis K
    J Med Virol; 2022 Jul; 94(7):2917-2918. PubMed ID: 35233795
    [No Abstract]   [Full Text] [Related]  

  • 2. Nutritional Modulation of Gut Microbiota Alleviates Severe Gastrointestinal Symptoms in a Patient with Post-Acute COVID-19 Syndrome.
    Wang Y; Wu G; Zhao L; Wang W
    mBio; 2022 Apr; 13(2):e0380121. PubMed ID: 35254129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inflammation-type dysbiosis of the oral microbiome associates with the duration of COVID-19 symptoms and long COVID.
    Haran JP; Bradley E; Zeamer AL; Cincotta L; Salive MC; Dutta P; Mutaawe S; Anya O; Meza-Segura M; Moormann AM; Ward DV; McCormick BA; Bucci V
    JCI Insight; 2021 Oct; 6(20):. PubMed ID: 34403368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gut Microbiome Imbalance and Neuroinflammation: Impact of COVID-19 on Parkinson's Disease.
    Follmer C
    Mov Disord; 2020 Sep; 35(9):1495-1496. PubMed ID: 32822087
    [No Abstract]   [Full Text] [Related]  

  • 5. Premises among SARS-CoV-2, dysbiosis and diarrhea: Walking through the ACE2/mTOR/autophagy route.
    de Oliveira AP; Lopes ALF; Pacheco G; de Sá Guimarães Nolêto IR; Nicolau LAD; Medeiros JVR
    Med Hypotheses; 2020 Nov; 144():110243. PubMed ID: 33254549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Post-acute COVID-19 syndrome and gut dysbiosis linger beyond 1 year after SARS-CoV-2 clearance.
    Su Q; Lau RI; Liu Q; Chan FKL; Ng SC
    Gut; 2023 Jun; 72(6):1230-1232. PubMed ID: 35940857
    [No Abstract]   [Full Text] [Related]  

  • 7. Gut Microbiome Alterations in COVID-19.
    Zuo T; Wu X; Wen W; Lan P
    Genomics Proteomics Bioinformatics; 2021 Oct; 19(5):679-688. PubMed ID: 34560321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gut microbiota dynamics in a prospective cohort of patients with post-acute COVID-19 syndrome.
    Liu Q; Mak JWY; Su Q; Yeoh YK; Lui GC; Ng SSS; Zhang F; Li AYL; Lu W; Hui DS; Chan PK; Chan FKL; Ng SC
    Gut; 2022 Mar; 71(3):544-552. PubMed ID: 35082169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coronavirus Disease (COVID-19) Caused by (SARS-CoV-2) Infections: A Real Challenge for Human Gut Microbiota.
    Vodnar DC; Mitrea L; Teleky BE; Szabo K; Călinoiu LF; Nemeş SA; Martău GA
    Front Cell Infect Microbiol; 2020; 10():575559. PubMed ID: 33363049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microbiota Modulation of the Gut-Lung Axis in COVID-19.
    de Oliveira GLV; Oliveira CNS; Pinzan CF; de Salis LVV; Cardoso CRB
    Front Immunol; 2021; 12():635471. PubMed ID: 33717181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gut bacterial dysbiosis and instability is associated with the onset of complications and mortality in COVID-19.
    Schult D; Reitmeier S; Koyumdzhieva P; Lahmer T; Middelhoff M; Erber J; Schneider J; Kager J; Frolova M; Horstmann J; Fricke L; Steiger K; Jesinghaus M; Janssen KP; Protzer U; Neuhaus K; Schmid RM; Haller D; Quante M
    Gut Microbes; 2022; 14(1):2031840. PubMed ID: 35174781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gut and airway microbiota and their role in COVID-19 infection and pathogenesis: a scoping review.
    Liu TFD; Philippou E; Kolokotroni O; Siakallis G; Rahima K; Constantinou C
    Infection; 2022 Aug; 50(4):815-847. PubMed ID: 34671922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of COVID-19 on the Intestinal Microbiome.
    Venegas-Borsellino C; Sankararaman S; Roche K; Burns J; Landis RM
    Curr Nutr Rep; 2021 Dec; 10(4):300-306. PubMed ID: 34813042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The pathophysiological mechanisms of COVID-19 and host immunity, with emphasis on the dysbiosis of the lung and gut microbiomes and pregnancy.
    Asai N; Kato H; Mikamo H
    Respir Investig; 2022 Jul; 60(4):496-502. PubMed ID: 35422403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Fungal Gut Microbiome Exhibits Reduced Diversity and Increased Relative Abundance of Ascomycota in Severe COVID-19 Illness and Distinct Interconnected Communities in SARS-CoV-2 Positive Patients.
    Reinold J; Farahpour F; Schoerding AK; Fehring C; Dolff S; Konik M; Korth J; van Baal L; Buer J; Witzke O; Westendorf AM; Kehrmann J
    Front Cell Infect Microbiol; 2022; 12():848650. PubMed ID: 35521219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alterations in Gut Microbiota of Patients With COVID-19 During Time of Hospitalization.
    Zuo T; Zhang F; Lui GCY; Yeoh YK; Li AYL; Zhan H; Wan Y; Chung ACK; Cheung CP; Chen N; Lai CKC; Chen Z; Tso EYK; Fung KSC; Chan V; Ling L; Joynt G; Hui DSC; Chan FKL; Chan PKS; Ng SC
    Gastroenterology; 2020 Sep; 159(3):944-955.e8. PubMed ID: 32442562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inflammatory effect on the gastrointestinal system associated with COVID-19.
    Delgado-Gonzalez P; Gonzalez-Villarreal CA; Roacho-Perez JA; Quiroz-Reyes AG; Islas JF; Delgado-Gallegos JL; Arellanos-Soto D; Galan-Huerta KA; Garza-Treviño EN
    World J Gastroenterol; 2021 Jul; 27(26):4160-4171. PubMed ID: 34326616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of Gut Microbiome in COVID-19: An Insight Into Pathogenesis and Therapeutic Potential.
    Hussain I; Cher GLY; Abid MA; Abid MB
    Front Immunol; 2021; 12():765965. PubMed ID: 34721437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Could Perturbation of Gut Microbiota Possibly Exacerbate the Severity of COVID-19
    Vignesh R; Swathirajan CR; Tun ZH; Rameshkumar MR; Solomon SS; Balakrishnan P
    Front Immunol; 2020; 11():607734. PubMed ID: 33569053
    [No Abstract]   [Full Text] [Related]  

  • 20. Viral Infection-Induced Gut Dysbiosis, Neuroinflammation, and α-Synuclein Aggregation: Updates and Perspectives on COVID-19 and Neurodegenerative Disorders.
    Follmer C
    ACS Chem Neurosci; 2020 Dec; 11(24):4012-4016. PubMed ID: 33244974
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.